Literature DB >> 21450824

Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product.

Joanne C G Tan1, Selmir Avdic, John Z Cao, Edward S Mocarski, Kirsten L White, Allison Abendroth, Barry Slobedman.   

Abstract

The human cytomegalovirus (HCMV) ORF94 gene product has been reported to be expressed during both productive and latent phases of infection, although its function is unknown. We report that expression of pORF94 leads to decreased 2',5'-oligoadenylate synthetase (OAS) expression in transfected cells with and without interferon stimulation. Furthermore, the functional activity of OAS was inhibited by pORF94. Finally, we present evidence of OAS modulation by pORF94 during productive HCMV infection of human fibroblasts. This study provides the first identification of a function for pORF94 and identifies an additional means by which HCMV may limit a critical host cell antiviral response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450824      PMCID: PMC3094971          DOI: 10.1128/JVI.02463-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity.

Authors:  Helle Kristiansen; Christina A Scherer; Maralee McVean; Shawn P Iadonato; Susanne Vends; Karthiga Thavachelvam; Thomas B Steffensen; Kristy A Horan; Thomas Kuri; Friedemann Weber; Søren R Paludan; Rune Hartmann
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

2.  Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals.

Authors:  K Kondo; J Xu; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

3.  Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.

Authors:  C Baglioni; M A Minks; P A Maroney
Journal:  Nature       Date:  1978-06-22       Impact factor: 49.962

4.  Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs.

Authors:  H Zhu; J P Cong; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  Human cytomegalovirus latent infection of granulocyte-macrophage progenitors.

Authors:  K Kondo; H Kaneshima; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

6.  Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.

Authors:  M J Clemens; B R Williams
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

7.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

8.  A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection.

Authors:  Christina Jenkins; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1.

Authors:  Stephanie J Child; Morgan Hakki; Katherine L De Niro; Adam P Geballe
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response.

Authors:  Davide A Abate; Shinya Watanabe; Edward S Mocarski
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more
  11 in total

Review 1.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

2.  Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.

Authors:  Praneet K Sandhu; Nicholas J Buchkovich
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

Review 3.  Human cytomegalovirus persistence.

Authors:  Felicia Goodrum; Katie Caviness; Patricia Zagallo
Journal:  Cell Microbiol       Date:  2012-03-08       Impact factor: 3.715

Review 4.  Modulation of the Translational Landscape During Herpesvirus Infection.

Authors:  Britt A Glaunsinger
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

Review 5.  Who's Driving? Human Cytomegalovirus, Interferon, and NFκB Signaling.

Authors:  Christopher M Goodwin; Jessica H Ciesla; Joshua Munger
Journal:  Viruses       Date:  2018-08-21       Impact factor: 5.048

Review 6.  Cytomegalovirus latency and reactivation: recent insights into an age old problem.

Authors:  Liane Dupont; Matthew B Reeves
Journal:  Rev Med Virol       Date:  2015-11-17       Impact factor: 6.989

7.  Abrogation of the interferon response promotes more efficient human cytomegalovirus replication.

Authors:  Brian P McSharry; Simone K Forbes; Selmir Avdic; Richard E Randall; Gavin W G Wilkinson; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

Review 8.  Recent advances in understanding viral evasion of type I interferon.

Authors:  Kathryne E Taylor; Karen L Mossman
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397

Review 9.  Human cytomegalovirus and autoimmune disease.

Authors:  Anne Halenius; Hartmut Hengel
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

Review 10.  Human cytomegalovirus manipulation of latently infected cells.

Authors:  John H Sinclair; Matthew B Reeves
Journal:  Viruses       Date:  2013-11-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.